Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Recombinant Activated Factor VII (rFVIIa)
BIOLOGICAL
2 trials
Sponsors
University of Utah
, Joseph Broderick, MD
Conditions
Intracerebral Hemorrhage
Intracranial Hemorrhage
Phase 1
Factor VII, Prothrombin Complex Concentrate, and Fresh Frozen Plasma in Warfarin-Related Intracranial Hemorrhage
Terminated
NCT00770718
University of Utah
Intracranial Hemorrhage
Start: 2008-04-30
End: 2010-04-30
Updated: 2011-11-24
Phase 3
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Active, not recruiting
NCT03496883
Joseph Broderick, MD
Intracerebral Hemorrhage
Start: 2021-12-03
End: 2028-01-01
Target: 860
Updated: 2026-01-21
Related Papers
Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial.
2023-07-01
17 citations
Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial
Stroke
2021-12-01
8 citations
Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial
International Journal of Stroke
2021-08-24
57 citations